Zevra Therapeutics Inc is a pioneering biopharmaceutical company. The US-based firm is dedicated to discovering, developing and commercialising transformative therapies in a relentless quest to conquer rare diseases.
Active within the healthcare sector, Zevra’s operations are focused on the creation of medicines designed to address the current shortcomings in treatments for these serious medical conditions. Its portfolio consists of clinical-stage pipeline and commercial-stage products that bring much-needed therapies to patients.
Diversify your virtual portfolio by following ZVRA shares on eToro.